Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Elekta, officially known as Elekta AB, is a leading provider of advanced solutions in the health and social work services industry, specialising in cancer care and neurosurgery. Headquartered in Stockholm, Sweden, the company operates globally, serving healthcare providers across Europe, North America, and other regions. Founded in 1972, Elekta has established a strong reputation for innovation in radiotherapy, radiosurgery, and brachytherapy, with its products recognised for precision and reliability.
The company's core offerings include sophisticated treatment planning systems, linear accelerators, and specialised software designed to optimise patient outcomes. Elekta’s commitment to technological advancement has positioned it as a key player in the medical device sector, with notable achievements in improving cancer treatment efficacy. Its focus on research and development continues to drive growth and maintain its market leadership in the health and social work services industry.
+61 vs industry average
Elekta’s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Health Services has typical carbon intensity
The Health Services industry has reduced its overall emissions by 23% since 2018
Scope 3 accounts for ••• of total emissions.
Elekta, headquartered in Sweden and operating in the Health and social work services sector, reported total emissions of approximately 490,941,000 kg CO2e for 2025. This figure comprises about 5,007,000 kg CO2e from Scope 1, approximately 3,181,000 kg CO2e (market-based) from Scope 2, and around 482,753,000 kg CO2e from Scope 3 emissions. In 2024, their total emissions were about 541,542,000 kg CO2e.
Elekta has set Science Based Targets initiative (SBTi) approved targets. They commit to reducing absolute Scope 1 and 2 GHG emissions by 46.2% by FY2031 from a FY2021 base year. Additionally, Elekta aims to increase its annual sourcing of renewable electricity from 61% in FY2021 to 100% by FY2030. For Scope 3, Elekta commits to reducing GHG emissions from the use of sold products and end-of-life treatment of sold products by 55% per radiotherapy cancer treatment course by FY2031 from a FY2021 base year. The company also targets that 45% of its suppliers, by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by FY2026.
2031
55% reduction in scope 3 total
Elekta AB commits to reduce absolute scope 1 and 2 GHG emission 46.2% by FY2031 from a FY2021 base year.* Elekta AB also commits to increase…
2031
46.2% reduction in Scope 2
2031
46.2% reduction in Scope 1
See all 6 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Elekta’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more